ReviewClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2026
Multidisciplinary management of advanced ovarian cancer in Spain: expert recommendations for achieving maximum survival and improving patient care.
Review in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In advanced ovarian cancer, developments in tumor profiling, surgical techniques, and maintenance therapies have led to increased numbers of "long-term survivors" who remain relapse-free beyond five years. These developments require identifying best practices for disease management and patient care to maximize the chances of long-term survival. To meet this need, we implemented the "Health Evidence Achieving Long Survival" (HEaLS) project, which aimed to develop guidelines for optimal management, follow-up, and patient support in advanced ovarian cancer. Through literature review and collaborative discussions, we formulated guidance for nine topics: clinical, pathological and molecular diagnosis, genetic counseling, surgery, systemic therapeutic management, oncology nursing, psycho-oncology, nutrition, physical exercise, and biopsychosocial needs. Here, we present our recommendations for managing advanced epithelial ovarian cancer focusing on integrated care pathways and multidisciplinary collaboration. These recommendations can be used by healthcare teams looking to implement coordinated strategies for maximizing survival and quality of life in ovarian cancer.
Indexed as
Identifiers
42410276What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.